Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
35%
OVERLAP
BY WEIGHT
7
# OF OVERLAPPING
HOLDINGS
MEDX
27
HOLDINGS
26%
ALSO IN THNR
THNR
19
HOLDINGS
37%
ALSO IN MEDX
SECTOR DRIFT (MEDX minus THNR)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX |
Weight in THNR |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 17.8% | 12.3% | 12.3% |
 |
ASTRAZENECA PLC-SPONS ADR | 5.3% | 4.8% | 4.8% |
|
ABBVIE INC | 8.4% | 4.6% | 4.6% |
|
AMGEN INC | 4.1% | 6.8% | 4.1% |
|
MERCK & CO. INC. | 3.6% | 5.1% | 3.6% |
MEDX Overweight Relative to THNR
 |
NOVARTIS AG-ADR | 7.0% |
|
ELI LILLY & CO | 5.5% |
|
JOHNSON & JOHNSON | 5.3% |
|
IONIS PHARMACEUTICALS, INC. | 5.0% |
|
BRISTOL-MYERS SQUIBB CO | 4.6% |
|
ALNYLAM PHARMACEUTICALS INC | 4.4% |
 |
ALKERMES PLC | 3.9% |
|
ABBVIE INC | 3.8% |
|
CRISPR THERAPEUTICS AG | 2.9% |
|
GLAXOSMITHKLINE PLC-SPON ADR | 2.8% |
MEDX Underweight Relative to THNR
 |
NOVO-NORDISK A/S-SPONS ADR | -14.6% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -6.5% |
|
SHIONOGI & CO LTD | -5.5% |
|
ROCHE HOLDING LTD | -5.2% |
 |
INNOVENT BIOLOGICS, INC. | -4.6% |
 |
CHINA PHARMACEUTICAL GROUP | -4.3% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -3.8% |
|
REGENERON PHARMACEUTICALS | -3.6% |
|
AMGEN INC | -2.8% |
|
HIMS & HERS HEALTH, INC. CLASS A | -2.8% |